Issue 51, 2022, Issue in Progress

Curcumin loaded Ag–TiO2-halloysite nanotubes platform for combined chemo-photodynamic therapy treatment of cancer cells

Abstract

The use of naturally occurring anticancer materials in combination with doped metal oxide has emerged as one of the most promising ways for improving anticancer treatment efficacy. In this study, the anticancer potential of curcumin-loaded Ag–TiO2-halloysite nanotubes (curcumin-loaded Ag–TiO2-HNTs) was examined. Ag–TiO2-HNTs with different wt% of Ag–TiO2 were synthesized and characterized using XRD, TGA, FT-IR, UV-Vis spectroscopy, and SEM-EDX. The XRD results revealed the presence of crystalline TiO2. However, the presence of Ag was detected through the SEM-EDX analysis. Cyclic voltammetry measurements suggested the enhancement of the release of ROS from TiO2 upon deposition with Ag. FT-IR and TGA analysis confirmed the successful loading of curcumin inside the nanotubes of the halloysite. In vitro drug released studies revealed the release of approximately 80–99% curcumin within 48 hours. Kinetic model studies revealed that the release of curcumin from HNT and Ag–TiO2-HNT followed the first-order and Higuchi models, respectively. The light irradiated curcumin-loaded Ag–TiO2-HNTs samples exhibited considerable anticancer potential as compared to the free curcumin, irradiated Ag–TiO2 NPs samples, and unirradiated curcumin loaded Ag–TiO2-HNTs samples. The obtained results revealed that combined chemo- and photodynamic therapy using curcumin-loaded Ag–TiO2-HNTs nanomaterial has the potential as an effective anticancer treatment method.

Graphical abstract: Curcumin loaded Ag–TiO2-halloysite nanotubes platform for combined chemo-photodynamic therapy treatment of cancer cells

Supplementary files

Article information

Article type
Paper
Submitted
13 Sep 2022
Accepted
15 Nov 2022
First published
18 Nov 2022
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2022,12, 33108-33123

Curcumin loaded Ag–TiO2-halloysite nanotubes platform for combined chemo-photodynamic therapy treatment of cancer cells

E. Nyankson, D. Awuzah, E. K. Tiburu, J. K. Efavi, B. Agyei-Tuffour and L. Paemka, RSC Adv., 2022, 12, 33108 DOI: 10.1039/D2RA05777H

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements